Skip to main content
main-content
Erschienen in: Archives of Osteoporosis 1/2022

01.12.2022 | Original Article

An optimal intervention threshold of FRAX in postmenopausal Thai women

verfasst von: Dueanchonnee Sribenjalak, Suranut Charoensri, Chatlert Pongchaiyakul

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Summary

This study was designed to determine a FRAX intervention threshold in postmenopausal Thais, based on a history of hip fracture. The optimal FRAX thresholds for hip fracture were 4.9% (without BMD) and 4% (with BMD), while the thresholds for major osteoporotic fracture were 9.8% (without BMD) and 8.9% (with BMD).

Introduction

Fracture Risk Assessment Tool (FRAX) has been widely used as an intervention threshold for initiating osteoporosis treatment. However, there is a lack of data to validate the threshold in Thai population.

Methods

A cross-sectional study was conducted from January 2014 to February 2019. Postmenopausal women in the Northeast of Thailand whom has bone mineral density (BMD) measured using dual-energy X-ray absorptiometry (DXA) in the study period were recruited. Participants who had previously received anti-osteoporotic treatment were not eligible. FRAX score, both with and without BMD, was calculated using a Thai reference. Prevalent hip fracture was identified by reviewing the ICD-10 diagnosis from the hospital database during the study period. The receiver operating characteristic (ROC) curve and Youden index were used to determine the FRAX threshold in predicting hip fracture, based on the rationale that women with a prevalent hip fracture would be eligible for treatment.

Results

A total of 2872 postmenopausal Thai women were recruited, with 45 sustained a recent hip fracture. In association with hip fracture, the optimal FRAX thresholds for hip fracture without and with BMD were 4.9% and 4%, respectively, with 71.1% sensitivity and 83.3% specificity, and 82.2% sensitivity and 78.6% specificity, while the optimal FRAX thresholds for major osteoporotic fracture (MOF) without and with BMD were 9.8% and 8.9%, respectively, with 75.6% sensitivity and 77.0% specificity, and 86.7% sensitivity and 70.9% specificity.

Conclusion

An optimal intervention threshold based on FRAX of hip fracture and MOF in postmenopausal Thai women is slightly different from the standard recommendation, which confirmed the marked variations of thresholds across ethnicities. The proposed threshold should be considered as new cutoff for initiating osteoporosis treatment in postmenopausal Thais.
Literatur
1.
Zurück zum Zitat Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al (2014) Clinician’s Guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381 CrossRef Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al (2014) Clinician’s Guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381 CrossRef
2.
Zurück zum Zitat Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6(2):99–105 CrossRef Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6(2):99–105 CrossRef
3.
Zurück zum Zitat Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA et al (2005) Hip Fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793 CrossRef Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA et al (2005) Hip Fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793 CrossRef
4.
Zurück zum Zitat Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen Y-T, Sherwood LM et al (2004) Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50–64 and 65 and older: Results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res 19(8):1215–1220 CrossRef Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen Y-T, Sherwood LM et al (2004) Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50–64 and 65 and older: Results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res 19(8):1215–1220 CrossRef
6.
Zurück zum Zitat Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033–1046 CrossRef Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033–1046 CrossRef
7.
Zurück zum Zitat Johansson H. FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int. 2017 Nov;28(11):3099–105. Johansson H. FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int. 2017 Nov;28(11):3099–105.
8.
Zurück zum Zitat Songpatanasilp T, Sritara C, Kittisomprayoonkul W, Chaiumnuay S, Nimitphong H, Charatcharoenwitthaya N et al (2016) Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis. Osteoporos Sarcopenia 2(4):191–207 CrossRef Songpatanasilp T, Sritara C, Kittisomprayoonkul W, Chaiumnuay S, Nimitphong H, Charatcharoenwitthaya N et al (2016) Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis. Osteoporos Sarcopenia 2(4):191–207 CrossRef
9.
Zurück zum Zitat Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV. A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. 2017;101. Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV. A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. 2017;101.
10.
Zurück zum Zitat Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437–447 CrossRef Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437–447 CrossRef
11.
Zurück zum Zitat Lekamwasam S (2013) Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 8(1–2):148 CrossRef Lekamwasam S (2013) Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 8(1–2):148 CrossRef
12.
Zurück zum Zitat Chandran M (2018) FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 13(1):130 CrossRef Chandran M (2018) FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 13(1):130 CrossRef
13.
Zurück zum Zitat Zhang Z, Ou Y, Sheng Z, Liao E (2014) How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine 45(2):195–197 CrossRef Zhang Z, Ou Y, Sheng Z, Liao E (2014) How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine 45(2):195–197 CrossRef
14.
Zurück zum Zitat Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX TM). Osteoporos Int. 2008;7. Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX TM). Osteoporos Int. 2008;7.
15.
Zurück zum Zitat Lekamwasam S, Chandran M, Subasinghe S (2019) Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka. Arch Osteoporos 14(1):33 CrossRef Lekamwasam S, Chandran M, Subasinghe S (2019) Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka. Arch Osteoporos 14(1):33 CrossRef
16.
Zurück zum Zitat Kanis J (2013) Commentary on guidelines on postmenopausal osteoporosis - Indian Menopause Society. J -Life Health 4(2):129–131 Kanis J (2013) Commentary on guidelines on postmenopausal osteoporosis - Indian Menopause Society. J -Life Health 4(2):129–131
17.
Zurück zum Zitat Chan D-C, McCloskey EV, Chang C-B, Lin K-P, Lim LC, Tsai K-S et al (2017) Establishing and evaluating FRAX® probability thresholds in Taiwan. J Formos Med Assoc Taiwan Yi Zhi 116(3):161–168 CrossRef Chan D-C, McCloskey EV, Chang C-B, Lin K-P, Lim LC, Tsai K-S et al (2017) Establishing and evaluating FRAX® probability thresholds in Taiwan. J Formos Med Assoc Taiwan Yi Zhi 116(3):161–168 CrossRef
18.
Zurück zum Zitat Chen JS, Simpson JM, Blyth FM, March LM (2014) Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort. Bone 69:148–153 CrossRef Chen JS, Simpson JM, Blyth FM, March LM (2014) Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort. Bone 69:148–153 CrossRef
19.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, McCloskey EV. The distribution of FRAXÒ-based probabilities in women from Japan. J Bone Min Metab. 2012;6. Kanis JA, Johansson H, Oden A, McCloskey EV. The distribution of FRAXÒ-based probabilities in women from Japan. J Bone Min Metab. 2012;6.
20.
Zurück zum Zitat Pongchaiyakul C, Songpattanasilp T, Taechakraichana N (2008) Burden of osteoporosis in Thailand. Int J Rheum Dis 11(4):335–340 CrossRef Pongchaiyakul C, Songpattanasilp T, Taechakraichana N (2008) Burden of osteoporosis in Thailand. Int J Rheum Dis 11(4):335–340 CrossRef
21.
Zurück zum Zitat Pongchaiyakul C, Leerapun T, Wongsiri S, Songpattanasilp T, Taechakraichana N (2012) Value and validation of RCOST and TOPF clinical practice guideline for osteoporosis treatment 95(12):8 Pongchaiyakul C, Leerapun T, Wongsiri S, Songpattanasilp T, Taechakraichana N (2012) Value and validation of RCOST and TOPF clinical practice guideline for osteoporosis treatment 95(12):8
22.
Zurück zum Zitat Chotiyarnwong P, Harvey NC, Johansson H, Liu E, Lorentzen M, Kanis JA et al (2019) Temporal changes in access to FRAX® in Thailand between 2010 and 2018. Arch Osteoporos 14(1):66 CrossRef Chotiyarnwong P, Harvey NC, Johansson H, Liu E, Lorentzen M, Kanis JA et al (2019) Temporal changes in access to FRAX® in Thailand between 2010 and 2018. Arch Osteoporos 14(1):66 CrossRef
23.
Zurück zum Zitat Hoang DK, Doan MC, Mai LD, Ho-Le TP, Ho-Pham LT. Burden of osteoporosis in Vietnam: an analysis of population risk. PLos One. 2021;16(6):e0252592. Hoang DK, Doan MC, Mai LD, Ho-Le TP, Ho-Pham LT. Burden of osteoporosis in Vietnam: an analysis of population risk. PLos One. 2021;16(6):e0252592.
Metadaten
Titel
An optimal intervention threshold of FRAX in postmenopausal Thai women
verfasst von
Dueanchonnee Sribenjalak
Suranut Charoensri
Chatlert Pongchaiyakul
Publikationsdatum
01.12.2022
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2022
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-022-01058-0

Weitere Artikel der Ausgabe 1/2022

Archives of Osteoporosis 1/2022 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, DICOM-Daten, Videos und Abbildungen. » Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Orthopädie und Unfallchirurgie und bleiben Sie gut informiert – ganz bequem per eMail.